Parameter | Gondar (current study) | Addis Ababa [17] | Kenya [6] | Burkina Faso (22) | Wintrobe [2] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sex | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | Median (95% range) | Mean ± SD | |
WBC (×109) | Female | 5.1 (3.2–8.8) | 5.3 ± 1.4 | 5.9 (3–12.2) | 6.2 ± 2.2 | 4.9 (3.0–9.1) | NA | 5.2 (3.4–7.4) | NA | NA (4.3–10) | 7.2 ± NA |
Male | 5.9 (3–9.8) | 6.0 ± 1.8 | 4.3 (2.7–7.5) | NA | 5.1 (3.2–9.2) | NA | NA (4.3–100) | 7.2 ± NA | |||
Platelet (×109) | Female | 264 (128–432) | 267 ± 76 | 193 (98–352) | 202 ± 67 | 251 (124–444) | NA | 252 (159–356) | NA | NA (150–450) | NA |
Male | 203 (97–324) | 207 ± 62 | 218 (115–366) | NA | 217 (127–365) | NA | NA (150–450) | NA | |||
Neutrophil (absolute) (×109) | Female | 2.7 (1.6–5.1) | 2.8 ± 0.9 | NA | NA | 1.96 (0.99–5.6) | NA | NA | NA | NA | NA |
Male | NA | NA | 1.78 (0.88–4.3) | NA | NA | NA | NA | NA | |||
Neutrophil (%) | Female | 53 (36–69) | 53 ± 8 | NA | NA | 42 (20–70) | NA | 46 (30–62) | NA | NA | NA |
Male | NA | NA | 42 (20–70) | NA | 43 (27–64) | NA | NA | NA | |||
Lymphocyte (absolute) (×109) | Female | 1.9 (1–3.5) | 2 ± 0.7 | 1.7 (1.09–3.5) | NA | 2.16 (1.29–4.0) | NA | 2.2 (1.4–3.2) | NA | NA | NA |
Male | (0.96–3.5) | NA | 1.86 (1.12–3.2) | NA | 2.1 (1.3–4.0) | NA | NA | NA | |||
Lymphocyte (%) | Female | 38 (22–55) | 37 ± 8 | (17–59) | 36 ± NA | 45 (20–60) | NA | 43 (27–57) | NA | NA | NA |
Male | (17–59) | 36 ± NA | 45 (20–60) | NA | 44 (26–60) | NA | NA | NA | |||
Mix cells (absolute) (×109) | Female | 0.5 (0.2–1) | 0.5 ± 0.2 | NA | NA | NA | NA | NA | NA | NA | NA |
Male | NA | NA | NA | NA | NA | NA | NA | NA | |||
Mixed cells (%) | Female | 9 (6–13) | 10 ± 2 | NA | NA | NA | NA | NA | NA | NA | NA |
Male | NA | NA | NA | NA | NA | NA | NA | NA |